Markers of subclinical target organ damage increase cardiovascular risk prediction beyond traditional risk factors. Arterial stiffness (AS) is one of these markers. 1 The predictive value for future cardiovascular events (CVEs) has been demonstrated for the carotido-femoral pulse wave velocity (PWV) in patients with renal failure, 2 in hypertensives, 3 and in the general population, 4 as well as from ambulatory measurement of the timing of Korotkoff sounds (QKD) in hypertensives. 5 The predictive value of AS is independent of traditional risk factors: sex, age, diabetes mellitus, smoking, cholesterol, and blood pressure (BP), even when monitored during 24 hours with the QKD method. However, very few studies 6 have compared the respective predictive values of different markers of target organ damage. This is a major issue because the question whether all parameters should be measured, or only some of them, in routine condition is opened. To date there are no studies that have evaluated the prognostic value of AS in comparison with another powerful risk factor, left ventricular mass (LVM) as measured by echocardiography in hypertensive patients We evaluated the prognostic value of these 2 parameters in the same population of patients with essential hypertension using the QKD method, which offers the advantages to combine 24-hour BP monitoring and an estimation of AS independent of BP.
Methods PopulationThe patients included in this study belong to the Bordeaux cohort of hypertensive. This registry was started in 1984 and includes all patients consecutively referred to our center before administration of antihypertensive treatment and fulfilling the following criteria:Office BP>140/90 on ≥2 occasions; Essential hypertension. Absence of cardiovascular complications or pathology likely to affect the prognosis, absence of type 1 diabetes mellitus.For the validity of the ambulatory measurement of AS, 2 other selection criteria were used.Absence of bundle-branch block on ECG (QRS duration <120 ms). Absence of known thyroid pathology.All the patients gave their consent to participation in this registry, which was approved by our local committee of ethics and protection
See Editorial Commentary, pp 10-12Abstract-Several studies have established that the increase in arterial stiffness (AS) is a cardiovascular risk factor but to date no studies have evaluated in hypertensive patients its prognostic value in comparison with another powerful risk factor, left ventricular mass (LVM) as measured by echocardiography. We prospectively evaluated the prognostic value of AS and LVM in patients with essential hypertension. The population studied comprised 793 patients (56% men) aged 54±14 years. For 519 patients, baseline measurements were made before any antihypertensive treatment, for 274 patients, the measurement were obtained during the follow-up period under antihypertensive treatment. AS was assessed from ambulatory monitoring of blood pressure and timing of Korottkoff sounds. Left ventricular mass was measured in 523 patients....